Fluxergy is working to transform diagnostic testing with the world's first multimodal testing platform (PCR, Immunochemistry, Chemistry and Cytometry). The Fluxergy system is designed to deliver test results within one hour (15-60 minutes depending on the test). The Fluxergy Diagnostic Testing System consists of the Fluxergy Card, which is a single-use “lab-on-chip” consumable test cartridge; the Fluxergy Analyzer, a highly integrated multidetection system, which conducts the testing process, and Fluxergy Works software, used to generate, analyze, and communicate the test data through cybersecure connectivity to third party cloud solutions (e.g. LIMS, EHR)
Nova Biomedical is a world leader in point-of-care and critical care whole blood diagnostic testing with products marketed in Hospitals, Clinics, A&E, and Blood Banks. Nova manufactures and sells StatStrip® hospital single-test meters for glucose, creatinine, Hb/Hct, and lactate testing. Our Stat Profile Prime Plus critical care blood gas analyzers feature maintenance-free, replaceable cartridge technology and a 22-test menu with gases, co-oximetry, metabolites, and electrolytes—including tests for ionized magnesium, urea, and creatinine.
Biokit is a biotechnology company that is part of Werfen with more than 45 years dedicated to the research, development and manufacture of Assay and Biomaterial for In Vitro diagnostics use. Biokit is one of the world's leading OEM (Original Equipment Manufacturer) companies in the development and manufacture of customized products and solutions for the In Vitro Diagnostics industry.
Werfen is a growing, privately held corporation that was founded in 1966 in Barcelona, Spain. We are a worldwide leader in in vitro diagnostics in the specialties of Hemostasis, Acute Care Diagnostics and Autoimmunity. At present, we operate directly in nearly 30 countries and 100 territories through distributors. Our R&D and production centers are located in the United States and Europe. In 2018, our revenues were 1,359M€ and we had a workforce of 5,155 people.
Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions, aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus in oncology which represents the fastest growing segment of the MDx market worldwide. Today, Biocartis offers tests supporting melanoma, colorectal and lung cancer, as well as tests for SARS-CoV-2 and sepsis.
Biocartis’ proprietary molecular diagnostics (MDx) IdyllaTM platform is a fully automated sample-to-result, real-time PCR system that offers accurate, highly reliable molecular information from virtually any biological sample, in virtually any setting, allowing fast and effective treatment selection and treatment progress monitoring.
PerkinElmer enables scientists, researchers and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, we deliver unique solutions to serve the diagnostics, life sciences, food and applied markets. We strategically partner to enable earlier and more accurate insights. Our dedicated team is passionate about helping customers to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally.
GenMark Diagnostics is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. GenMark’s ePlex®: The True Sample-to-Answer Solution® is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections.
A global leader of IVD for more than 50 years, bioMérieux continues to play a pioneering role by providing high medical value diagnostics to aid clinical decisions. BioFire® FilmArray® is our innovative rapid syndromic diagnostic solution for Meningitis/Encephalitis, Respiratory and Gastrointestinal disease and Blood stream Infections. With comprehensive results provided in around an hour, BioFire testing assists with patient management decisions in a clinically relevant time-frame.
GenPrime, Inc. is a leading provider of microbial detection and diagnostic analysis technologies. Our products eliminate subjectivity and human bias to bring rapid point-of-care testing into the future. GenPrime’s technology provides only the highest levels of accuracy & simplified workflow by securely & seamlessly connecting key information with test providers, medical records, and healthcare & industry professionals. It is these state-of-the-art technologies that are behind today's best analysis products and are forming tomorrow's cutting-edge designs.
Out of Würzburg, Germany, our offering covers all the raw materials required for the successful establishment very diverse IVD assays:
Boasting one of the largest portfolios for infectious diseases diagnostic in the market and distributors in 82 countries, we look forward to partnering up to improve healthcare worldwide.
Universal Biosensors (UBI) began its journey focusing on the research, development and manufacture of devices for the diagnostic point of care (POC) market using UBI’s core technology of a disposable, multi-layer test strip, which incorporates a proprietary electrochemical sensing system that rapidly and accurately measures different biomarkers in blood.
Building upon the success of these globally launched products, UBI continues to focus on the diagnostic POC market and is now exploring the opportunities this technology offers of speed, ease of use, reliability, accuracy at a low cost in alternative industries.
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers